By Professor (Keith) Chee Ooi

Preprints

E TK; Wakefield CE; Signorelli C; Day A; Vernon-Roberts A; Ooi CY, Gastroenterology services for patients with Cystic Fibrosis across Australia and New Zealand: A multi-stakeholder assessment of patients’ and professionals’ perspectives, http://dx.doi.org/10.22541/au.168271385.50624670/v1

Wong SL; Awatade NT; Astore MA; Allan KM; Carnell MJ; Slapetova I; Chen P-C; Capraro A; Fawcett LK; Whan RM; Griffith R; Ooi CY; Kuyucak S; Jaffe A; Waters SA, In silico and functional characterisation of an ultra-rare CFTR mutation identifies novel lasso motif interactions regulating channel gating, http://dx.doi.org/10.1101/2021.12.12.472297

Goddard TR; Carlson-Jones JA; Morton J; Ooi CY; Tai A; Warner MS; Wong J; Evans IE; Hopkins E; Iredell JR; Jersmann HP; Whiteson KL; Bouras G; Doane MP; Falk NW; Green R; Grigson SR; Mallawaarachchi V; Martin B; Roach MJ; Ryan FJ; Tarasenko A; Papudeshi B; Drigo B; Giles SK; Harker CM; Hesse RD; Hodgson RJ; Hussnain A; Hutton A; Inglis LK; Keneally C; Kerr EN; Liddicoat C; Peddle SD; Watson CD; Yang Q; Decewicz P; Speck PG; Mitchell JG; Dinsdale EA; Edwards RA, Microbial Ecological Signatures Predict Pathogen Emergence and Multidrug Resistance in Cystic Fibrosis Airways up to a Year in Advance, http://dx.doi.org/10.64898/2025.12.28.25342520

Wong SL; Awatade NT; Astore MA; Allan KM; Carnell MJ; Slapetova I; Chen P-C; Setiadi J; Pandzic E; Fawcett LK; Widger JR; Whan RM; Griffith R; Ooi CY; Kuyucak S; Jaffe A; Waters SA, Molecular dynamics and theratyping in airway and gut organoids reveal R352Q-CFTR conductance defect, http://dx.doi.org/10.1101/2021.08.11.456003

Coffey MJ; van Dorst J; Pushpakumara BLDU; Halim J; Hudson J; Plush L; Christi K; Foster C; Carzino R; Zajakovski N; Appleton L; Cheney J; Wood J; Monaghan SJ; Rawlinson W; Day AS; Oliver M; Ranganathan S; Selvadurai H; Wainwright C; Thomas T; Jaffe A; Ooi CY, Probiotics and the EARly Life effects on intestinal bacteria and inflammation in children with Cystic Fibrosis (The “PEARL-CF” Study), http://dx.doi.org/10.64898/2025.12.04.25341620

Perron JE; Coffey MJ; Lovell-Simons A; Dominguez L; King ME; Ooi CY, Resuscitating Cardiopulmonary Resuscitation Training in a Virtual Reality: Prospective Interventional Study (Preprint), http://dx.doi.org/10.2196/preprints.22920

Umashankar B; Capraro A; Vijayan A; Wong SL; Nielsen BU; Zhong L; Raftery M; Allan K; Ooi CY; Sivam S; Visser S; Prentice BJ; Fawcett L; Kovacevic Z; Eliasson L; Faurholt-Jepsen D; Jaffe A; Shaw JA; Vafaee F; Waters SA, Serum Exosomal Multi-Omic Signatures Stratify Glucose Tolerance in Cystic Fibrosis and Reveal Partial Therapeutic Reprogramming by CFTR Modulators, http://dx.doi.org/10.1101/2025.07.07.25331056

Williams IAR; van Dorst J; Leigh S-J; Baracz SJ; Pushpakumara BLDU; Marcus A; McCaffrey D; Walker AK; Ooi CY; Ward MC; Oei J-L; Clemens KJ, Sodium Butyrate Rescues Neurodevelopmental Deficits Following Perinatal Methadone Exposure, http://dx.doi.org/10.1101/2025.06.26.661851

Clemens K; Williams I; Dorst JV; Leigh S-J; Baracz S; Pushpakumara BLDU; Marcus A; McCaffrey D; Walker A; Ooi C; Ward M; Oei J-L, Sodium Butyrate Rescues Neurodevelopmental Deficits Following Perinatal Methadone Exposure, http://dx.doi.org/10.21203/rs.3.rs-9066876/v1

Chan C; Coffey M; Murphy C; McKay I; Abdu J; Paida K; Tam R; Wrigley-Carr H; Prentice B; Owens L; Belessis Y; Chuang S; Jaffe A; van Dorst J; Ooi CY, The Prevalence of pks+ E. coli in Cystic Fibrosis, http://dx.doi.org/10.20944/preprints202502.0874.v1

Back to profile page